Mar 09, 2021
Immutep Secures Second United States Patent Grant For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor
Mar 05, 2021
Immutep Expands Part B of TACTI-002 Study
Jan 26, 2021
Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study
Jan 21, 2021
Immutep Quarterly Activities Report
Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
